Abstract
Angelman syndrome (AS) is a human genetic disorder characterized by mental retardation, seizures, inappropriate laughter, abnormal gait, tremor and ataxia1–3. There is strong genetic evidence that the disorder is associated with a maternally expressed, imprinted gene mapping to chromosome 15q11–13. Affected patients demonstrate varied molecular abnormalities including large maternal deletions, uniparental paternal disomy (UPD), imprinting mutations4 and loss of function mutations of E6–associated-protein (E6-AP) ubiquitin–protein ligase (UBE3A)5,6. All of these abnormalities are associated with loss of maternal expression of UBE3A. Although mutations in UBE3A cause AS, indicating that maternal-specific expression of UBE3A is essential for a normal phenotype, evidence for maternal-specific expression of UBE3A has been lacking7,8. Using mice with partial paternal UPD encompassing Ube3a to differentiate maternal and paternal expression, we found by in situ hybridization that expression of Ube3a in Purkinje cells, hippocampal neurons and mitral cells of the olfactory bulb in UPD mice was markedly reduced compared to non-UPD littermates. In contrast, expression of Ube3a in other regions of the brain was only moderately or not at all reduced in UPD mice. The major phenotypic features of AS correlate with the loss of maternal-specific expression of Ube3a in hippocampus and cerebellum as revealed in the mouse model.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nicholls, R.D. New insights reveal complex mechanisms involved in genomic imprinting. Am. J. Hum. Genet. 54, 733–740 (1994).
Ledbetter, D.H., Ballabio, A. Molecular cytogenetics of contiguous gene syndromes: mechanisms and consequences of gene dosage imbalance. in The Metabolic and Molecular Bases of Inherited Disease, 7th ed. (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 811–839 (McGraw-Hill, New York, 1995).
Williams, C.A. et al. Angelman syndrome. Curr. Probl. Pediatr. 25, 216–231 (1995).
Buiting, K. et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nature Genet. 9, 395–400 (1995).
Matsuura, T. et al. De novo truncating mutations in E6-AP ubiquitin–protein ligase gene (UBE3A) in Angelman syndrome. Nature Genet. 15, 74–77 (1997).
Kishino, T., Lalande, M. & Wagstaff, J. UBE3A/E6-AP mutations cause Angelman syndrome. Nature Genet. 15, 70–73 (1997).
Nakao, M. et al. Imprinting analysis of three genes in the Prader–Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E). Hum. Mol. Genet. 3, 309–315 (1994).
Sutcliffe, J.S. et al. The E6–AP ubiquitin–protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res. 7, 368–377 (1997).
Magenis, R.E., Brown, M.G., Lacy, D.A., Budden, S. & LaFranchi, S. Is Angelman syndrome an alternate result of del(15)(q11q13)? Am. J. Med. Genet. 28, 829–838 (1987).
Zackowski, J.L. et al. Cytogenetic and molecular analysis in Angelman syndrome. Am. J. Med. Genet. 46, 7–11 (1993).
Knoll, J.H.M. et al. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am. J. Med. Genet. 32, 285–290 (1989).
Williams, C.A. et al. Maternal origin of 15q11-13 deletions in Angelman syndrome suggests a role for genomic imprinting. Am. J. Med. Genet. 35, 350–353 (1990).
Malcolm, S. et al. Uniparental paternal disomy in Angelman's syndrome. Lancet 337, 694–697 (1991).
Reis, A. et al. Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am. J. Hum. Genet. 54, 741–747 (1994).
Cattanach, B. et al. A mouse model of Angelman syndrome. Mamm. Genome 8, 472–478 (1997).
van Hille, B., Vanek, M., Richener, H., Green, J.R. & Bilbe, G. Cloning and tissue distribution of subunits C, D, and E of the human vacuolar H+-ATPase. Biochem. Biophys. Res. Commun. 197, 15–21 (1993).
Jay, V., Becker, I.E., Chan, F.-W. & Perry, T.L. Puppet-like syndrome of Angelman: a pathologic and neurochemical study. Neurology 41, 416–422 (1991).
Kyriakidas, T., Hallam, L.A., Hockey, A., Silberstein, P. & Kakulas, B.A. Angelman's syndrome: a neuropathological study. Acta Neuropathol. 83, 675–678 (1992).
Huibregtse, J.M., Scheffner, M. & Howley, P.M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell Biol. 13, 775–784 (1993).
Scheffner, M., Nuber, U. & Huibregtse, J.M. Protein ubiquitinatipn involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81–83 (1995).
Vu, T.H. & Hoffman, A.R. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 371, 714–717 (1994).
DeChiara, T.M., Robertson, E.J. & Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849–859 (1991).
Albrecht, U., Eichele, G., Helms, J.A. & Lu, H.-C. Visualization of gene expression patterns by in situ hybridization. in Molecular and Cellular Methods in Developmental Toxicology (ed. Daston, G.P.) 23–48 (CRC Press, Boca Raton, FL 1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Albrecht, U., Sutcliffe, J., Cattanach, B. et al. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet 17, 75–78 (1997). https://doi.org/10.1038/ng0997-75
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0997-75
This article is cited by
-
Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome
Nature Communications (2023)
-
Contextual fear memory impairment in Angelman syndrome model mice is associated with altered transcriptional responses
Scientific Reports (2023)
-
Novel epigenetic molecular therapies for imprinting disorders
Molecular Psychiatry (2023)
-
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Journal of Neurodevelopmental Disorders (2023)
-
Parent Description of Anxiety in Angelman Syndrome
Journal of Autism and Developmental Disorders (2022)